Georgi Dimitrov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Georgi Dimitrov has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Maya Danovska
Department of Neurology, University Hospital, Medical University, Pleven, Bulgaria
3 shared publications - Diana Marinova
Med Univ, Univ Hosp, Dept Neurol, Pleven, Bulgaria
2 shared publications - Eleonora Mineva-Dimitrova
Medical University Pleven, Pleven, Bulgaria
1 shared publication - Joana Simeonova
Department of Social and Preventive Medicine and Disaster Medicine, Faculty of Public Health, Medical University, 1527 Sofia, Bulgaria
1 shared publication - Plamen G. Stoev
Department of Neurology, University Hospital, Medical University, Pleven, Bulgaria
1 shared publication - Veronika Vasileva
Department of Neurology, University Hospital, Medical University, Pleven, Bulgaria
1 shared publication
Latest Publications
- 2 April 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (2) , 6792-6796
LIPID PROFILE AND STATIN THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE ISCHEMIC STROKE RECEIVING ANTICOAGULANT THERAPY
Purpose: To evaluate the association of lipid profile and statin therapy with stroke severity and early functional outcome in anticoagulated patients with atrial fibrillation (AF) hospitalized with acute ischemic stroke (IS). Materials and methods: This prospective, single-center cohort study included consecutive patients with acute IS and documented AF who were receiving oral anticoagulant therapy prior to stroke onset, including direct oral anticoagulants or vitamin K antagonists with therapeutic INR values. Demographic characteristics, comorbidities, lipid profile, and clinical risk scores were recorded on admission. Stroke severity was assessed using the NIHSS, and early functional outcome was evaluated using the modified Rankin Scale at discharge. Results: A total of 55 patients were included (median age 79 years; 40% male). Prior statin therapy was identified in 40% of patients. Patients receiving statins had significantly lower LDL-C levels at admission. However, no significant differences were observed between statin-treated and non-treated patients regarding stroke severity, early functional outcome, or in-hospital mortality. Notably, statin-treated patients exhibited a higher baseline clinical risk profile, reflected by higher CHA2DS2-VASc and HAS-BLED scores and a greater prevalence of prior IS. Conclusion: In anticoagulated patients with AF presenting with acute IS, lipid profile and statin therapy were not primary determinants of early stroke severity or functional outcome. Comparable outcomes among statin-treated patients despite a higher baseline risk suggest that dyslipidemia may influence the clinical course of IS in a more indirect manner. This single-center study highlights the need for further investigation to clarify the role of lipid-related mechanisms beyond anticoagulation.
- 2 April 2026
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 32 (2) , 6792-6796
LIPID PROFILE AND STATIN THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE ISCHEMIC STROKE RECEIVING ANTICOAGULANT THERAPY
Purpose: To evaluate the association of lipid profile and statin therapy with stroke severity and early functional outcome in anticoagulated patients with atrial fibrillation (AF) hospitalized with acute ischemic stroke (IS). Materials and methods: This prospective, single-center cohort study included consecutive patients with acute IS and documented AF who were receiving oral anticoagulant therapy prior to stroke onset, including direct oral anticoagulants or vitamin K antagonists with therapeutic INR values. Demographic characteristics, comorbidities, lipid profile, and clinical risk scores were recorded on admission. Stroke severity was assessed using the NIHSS, and early functional outcome was evaluated using the modified Rankin Scale at discharge. Results: A total of 55 patients were included (median age 79 years; 40% male). Prior statin therapy was identified in 40% of patients. Patients receiving statins had significantly lower LDL-C levels at admission. However, no significant differences were observed between statin-treated and non-treated patients regarding stroke severity, early functional outcome, or in-hospital mortality. Notably, statin-treated patients exhibited a higher baseline clinical risk profile, reflected by higher CHA2DS2-VASc and HAS-BLED scores and a greater prevalence of prior IS. Conclusion: In anticoagulated patients with AF presenting with acute IS, lipid profile and statin therapy were not primary determinants of early stroke severity or functional outcome. Comparable outcomes among statin-treated patients despite a higher baseline risk suggest that dyslipidemia may influence the clinical course of IS in a more indirect manner. This single-center study highlights the need for further investigation to clarify the role of lipid-related mechanisms beyond anticoagulation.
- Open Access
- 7 July 2024
- Published by Pensoft Publishers in Journal of Biomedical and Clinical Research
- Vol. 17 (2) , 157-166
A prospective study of age-related differences in modifiable risk factors, stroke subtype, and functional outcome in young and middle-aged patients with first-ever ischemic stroke
The objective of our study was to compare the age-related differences in the prevalence of modifiable risk factors (RF), stroke subtype and functional outcome at hospital discharge in young and middle-aged patients with first-ever ischemic stroke (IS). The study included 120 patients with acute first-ever IS, aged 18–59 years, admitted to the Neurology Clinic of Dr. Georgi Stranski University Hospital, Pleven. Of these, 41 (34.2%) were in the young-age group and 79 (65.8%) were middle-aged. The middle-aged patients had higher rates of arterial hypertension (81.0%), diabetes mellitus (45.6%), dyslipidemia (83.5%), low levels of HDL cholesterol (68.4%), high levels of LDL cholesterol (72.2%) and arterial fibrillation (7.6%). The most common subtype of IS in middle-aged patients was large artery atherosclerosis (40.5%), small vessel occlusion (29.1%) and cardioembolism (6.3%). In comparison, we found a higher incidence of IS in the young patients with other determined (34.1%) and undetermined aetiology (34.1%). Our data on functional outcomes at hospital discharge confirm age-related differences in the prevalence of modifiable RFs and stroke subtype in young and middle-aged patients with first-ever IS. These findings highlight the need to develop specific therapeutic approaches for early identification and effective control of health- and lifestyle-related RFs to reduce the incidence of the most common subtypes of IS.
- 7 July 2024
- Published by Pensoft Publishers in Journal of Biomedical and Clinical Research
- Vol. 17 (2) , 157-166
Open AccessA prospective study of age-related differences in modifiable risk factors, stroke subtype, and functional outcome in young and middle-aged patients with first-ever ischemic stroke
The objective of our study was to compare the age-related differences in the prevalence of modifiable risk factors (RF), stroke subtype and functional outcome at hospital discharge in young and middle-aged patients with first-ever ischemic stroke (IS). The study included 120 patients with acute first-ever IS, aged 18–59 years, admitted to the Neurology Clinic of Dr. Georgi Stranski University Hospital, Pleven. Of these, 41 (34.2%) were in the young-age group and 79 (65.8%) were middle-aged. The middle-aged patients had higher rates of arterial hypertension (81.0%), diabetes mellitus (45.6%), dyslipidemia (83.5%), low levels of HDL cholesterol (68.4%), high levels of LDL cholesterol (72.2%) and arterial fibrillation (7.6%). The most common subtype of IS in middle-aged patients was large artery atherosclerosis (40.5%), small vessel occlusion (29.1%) and cardioembolism (6.3%). In comparison, we found a higher incidence of IS in the young patients with other determined (34.1%) and undetermined aetiology (34.1%). Our data on functional outcomes at hospital discharge confirm age-related differences in the prevalence of modifiable RFs and stroke subtype in young and middle-aged patients with first-ever IS. These findings highlight the need to develop specific therapeutic approaches for early identification and effective control of health- and lifestyle-related RFs to reduce the incidence of the most common subtypes of IS.
- 3 January 2023
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 29 (1) , 4793-4799
GENDER-RELATED DIFFERENCES IN MODIFIABLE RISK FACTORS AND ISCHEMIC STROKE SUBTYPE IN YOUNG AND MIDDLE-AGED PATIENTS – A PROSPECTIVE STUDY
Background: Male and female patients differ in their risk factors (RFs) and ischemic stroke (IS) subtype. A better understanding of the gender–related differences an important approach to successful prevention strategies for reducing the impact and burden of IS in young adults. Objective: To compare the gender–related differences in the prevalence of modifiable RFs and IS subtypes in young and middle-aged patients. Material and Methods: In the study were included 80 patients with acute IS, aged 18 – 59 years, admitted to the Neurology Clinic of UMHAT "Dr Georgi Stranski" Pleven. The following RFs were analyzed: arterial hypertension (AH), diabetes mellitus (DM), dyslipidemia, atrial fibrillation (AF), current smoking, number of cigarettes smoked per day, alcohol abuse, low physical activity, body overweight and chronic psychosocial stress. IS subtype was identified according to the Org 10172 Trial of Acute Stroke (TOAST). The statistical analysis was performed with the Statistical Package for Social Sciences, version 26.0 (SPSS). Results: Of all the 80 patients, 46 (57,5%) were males with a mean age 48,15±7,42 years, and 34 (42,5%) were females with a mean age 47,38±8,56. Male patients had higher rates of AH (80,4%), DM (47.8%), AF (4,3%), current smoking (73,9%), number of cigarettes smoked per day (60,9%), alcohol abuse (41,3%) and chronic psychosocial stress (52,2%), while the female ones showed higher rates of low physical activity (61,8%) and body overweight (38,2%). A statistical significance was found only for AH (p=0,004), DM (p=0,026), current smoking (p=0,007), number of cigarettes smoked per day (p=0,025) and alcohol abuse (p=0,031). The most common subtype of IS in males was large artery atherosclerosis (47,8%) and small vessel occlusion (28,3%). The female patients demonstrated a higher frequency of IS with other determined etiology (38,2%) and undetermined etiology (26,5%). Conclusion: Our data contribute to a better understanding of the gender–related differences of modifiable RFs and IS subtype in young and middle-aged patients with acute IS. The above findings definitely imply the necessity of developing additional specific therapeutic strategies for the effective control of modifiable RFs and lifestyle improvement in order to reduce the incidence of the most common subtypes of IS.
- 3 January 2023
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 29 (1) , 4793-4799
GENDER-RELATED DIFFERENCES IN MODIFIABLE RISK FACTORS AND ISCHEMIC STROKE SUBTYPE IN YOUNG AND MIDDLE-AGED PATIENTS – A PROSPECTIVE STUDY
Background: Male and female patients differ in their risk factors (RFs) and ischemic stroke (IS) subtype. A better understanding of the gender–related differences an important approach to successful prevention strategies for reducing the impact and burden of IS in young adults. Objective: To compare the gender–related differences in the prevalence of modifiable RFs and IS subtypes in young and middle-aged patients. Material and Methods: In the study were included 80 patients with acute IS, aged 18 – 59 years, admitted to the Neurology Clinic of UMHAT "Dr Georgi Stranski" Pleven. The following RFs were analyzed: arterial hypertension (AH), diabetes mellitus (DM), dyslipidemia, atrial fibrillation (AF), current smoking, number of cigarettes smoked per day, alcohol abuse, low physical activity, body overweight and chronic psychosocial stress. IS subtype was identified according to the Org 10172 Trial of Acute Stroke (TOAST). The statistical analysis was performed with the Statistical Package for Social Sciences, version 26.0 (SPSS). Results: Of all the 80 patients, 46 (57,5%) were males with a mean age 48,15±7,42 years, and 34 (42,5%) were females with a mean age 47,38±8,56. Male patients had higher rates of AH (80,4%), DM (47.8%), AF (4,3%), current smoking (73,9%), number of cigarettes smoked per day (60,9%), alcohol abuse (41,3%) and chronic psychosocial stress (52,2%), while the female ones showed higher rates of low physical activity (61,8%) and body overweight (38,2%). A statistical significance was found only for AH (p=0,004), DM (p=0,026), current smoking (p=0,007), number of cigarettes smoked per day (p=0,025) and alcohol abuse (p=0,031). The most common subtype of IS in males was large artery atherosclerosis (47,8%) and small vessel occlusion (28,3%). The female patients demonstrated a higher frequency of IS with other determined etiology (38,2%) and undetermined etiology (26,5%). Conclusion: Our data contribute to a better understanding of the gender–related differences of modifiable RFs and IS subtype in young and middle-aged patients with acute IS. The above findings definitely imply the necessity of developing additional specific therapeutic strategies for the effective control of modifiable RFs and lifestyle improvement in order to reduce the incidence of the most common subtypes of IS.